Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines ; volume:10 ; number:1 ; day:31 ; month:7 ; year:2012 ; pages:1-7 ; date:12.2012
Journal of translational medicine ; 10, Heft 1 (31.7.2012), 1-7, 12.2012
- Urheber
-
Accolla, Roberto S.
- Beteiligte Personen und Organisationen
-
Tosi, Giovanna
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-10-154
- URN
-
urn:nbn:de:1111-2016041441065
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Accolla, Roberto S.
- Tosi, Giovanna
- SpringerLink (Online service)
Ähnliche Objekte (12)
Vaccines targeting the neovasculature of tumors
Selected anti-tumor vaccines merit a place in multimodal tumor therapies
Semi-allogeneic vaccines and tumor-induced immune tolerance
Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines
Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity
Advances and applications of RNA vaccines in tumor treatment
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Cancer vaccines: shared tumor antigens return to the spotlight
Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy
Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma
Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)
Vaccines targeting the neovasculature of tumors
Selected anti-tumor vaccines merit a place in multimodal tumor therapies
Semi-allogeneic vaccines and tumor-induced immune tolerance
Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines
Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity
Advances and applications of RNA vaccines in tumor treatment
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Cancer vaccines: shared tumor antigens return to the spotlight
Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy
Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma
Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)
Vaccines targeting the neovasculature of tumors
Selected anti-tumor vaccines merit a place in multimodal tumor therapies
Semi-allogeneic vaccines and tumor-induced immune tolerance
Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines
Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity
Advances and applications of RNA vaccines in tumor treatment
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Cancer vaccines: shared tumor antigens return to the spotlight
Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy
Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma
Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy